Sangamo Therapeutics Q4 EPS $(0.34) Misses $(0.26) Estimate, Sales $2.04M Miss $8.10M Estimate
Author: Happy Mohamed | March 13, 2024 08:15am
Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.26) by 30.77 percent. This is a 6.25 percent decrease over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $2.04 million which missed the analyst consensus estimate of $8.10 million by 74.79 percent. This is a 92.50 percent decrease over sales of $27.23 million the same period last year.
Posted In: SGMO